Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Chen Y, Du C, Shen S, Zhang W, Shan Y, Lyu A, Wu J, Shang C, Luo X, Wei J, Xiao H, Qiu J, Hua Y, Wang S, Wang T, Dai S, Zhang S, Xie B, Wu Y, Hao C.
Chen Y, et al. Among authors: hua y.
Clin Cancer Res. 2024 Jul 15;30(14):2937-2944. doi: 10.1158/1078-0432.CCR-24-0006.
Clin Cancer Res. 2024.
PMID: 38687583
Clinical Trial.